Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yuxin Liu, M.D.

Concepts (132)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Yuxin Liu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Yuxin Liu has written about over time.
Antibodies, Antinuclear, 1 publications between 2015 and 2015, average publication date July 2015. Liver Diseases, 1 publications between 2015 and 2015, average publication date July 2015. Lupus Erythematosus, Systemic, 2 publications between 2015 and 2016, average publication date March 2016. Ethmoid Sinus, 1 publications between 2016 and 2016, average publication date September 2016. Antibodies, Antiphospholipid, 1 publications between 2016 and 2016, average publication date November 2016. Electron Transport Chain Complex Proteins, 1 publications between 2016 and 2016, average publication date November 2016. Mitochondria, Liver, 1 publications between 2016 and 2016, average publication date November 2016. Sirolimus, 3 publications between 2015 and 2018, average publication date November 2016. Isotope Labeling, 1 publications between 2018 and 2018, average publication date April 2018. Immunotherapy, 1 publications between 2018 and 2018, average publication date December 2018. Leukemia, Myeloid, Acute, 1 publications between 2018 and 2018, average publication date December 2018. Myelodysplastic Syndromes, 1 publications between 2018 and 2018, average publication date December 2018. Carcinoma, Squamous Cell, 1 publications between 2019 and 2019, average publication date December 2018. Head and Neck Neoplasms, 1 publications between 2019 and 2019, average publication date December 2018. Skin Neoplasms, 1 publications between 2019 and 2019, average publication date December 2018. Central Nervous System Neoplasms, 2 publications between 2019 and 2022, average publication date July 2020. Antimetabolites, Antineoplastic, 1 publications between 2022 and 2022, average publication date January 2022.

To see the data from this visualization as text, click here.
Liu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (132)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.